Xiaoran Ma

770 total citations
36 papers, 541 citations indexed

About

Xiaoran Ma is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaoran Ma has authored 36 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaoran Ma's work include Cancer-related molecular mechanisms research (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and RNA modifications and cancer (4 papers). Xiaoran Ma is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and RNA modifications and cancer (4 papers). Xiaoran Ma collaborates with scholars based in China, United States and Sweden. Xiaoran Ma's co-authors include Changgang Sun, Cun Liu, Jing Zhuang, Lijuan Liu, Huayao Li, Jie Li, Chundi Gao, Jibiao Wu, Jing Zhuang and Li Ye and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Hazardous Materials and Scientific Reports.

In The Last Decade

Xiaoran Ma

34 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoran Ma China 14 289 141 81 66 49 36 541
Yuanqiao He China 19 329 1.1× 134 1.0× 101 1.2× 51 0.8× 111 2.3× 61 742
Liangjie Yin United States 12 266 0.9× 78 0.6× 74 0.9× 82 1.2× 55 1.1× 30 712
Minghua Liu China 14 255 0.9× 116 0.8× 57 0.7× 53 0.8× 53 1.1× 39 568
Yun Zhan China 12 363 1.3× 198 1.4× 50 0.6× 40 0.6× 43 0.9× 17 572
Izabela Berdowska Poland 13 223 0.8× 122 0.9× 85 1.0× 55 0.8× 64 1.3× 27 706
Desanka Výbohová Slovakia 17 288 1.0× 101 0.7× 112 1.4× 45 0.7× 49 1.0× 30 649
Fanying Meng China 18 333 1.2× 231 1.6× 145 1.8× 81 1.2× 54 1.1× 57 841
Xin Su China 14 280 1.0× 143 1.0× 63 0.8× 104 1.6× 38 0.8× 37 544
Mahmood Husain Qazi Pakistan 13 253 0.9× 83 0.6× 56 0.7× 39 0.6× 40 0.8× 24 584
Yao Fong Taiwan 16 334 1.2× 102 0.7× 96 1.2× 96 1.5× 35 0.7× 28 780

Countries citing papers authored by Xiaoran Ma

Since Specialization
Citations

This map shows the geographic impact of Xiaoran Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoran Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoran Ma more than expected).

Fields of papers citing papers by Xiaoran Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoran Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoran Ma. The network helps show where Xiaoran Ma may publish in the future.

Co-authorship network of co-authors of Xiaoran Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoran Ma. A scholar is included among the top collaborators of Xiaoran Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoran Ma. Xiaoran Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Ling, Tiantian Wang, Xiaoran Ma, et al.. (2024). Puerarin inhibits macrophage M1 polarization by combining STAT1 to reduce myocardial damage in EAM model mice. Biochemical and Biophysical Research Communications. 733. 150702–150702. 4 indexed citations
2.
Ma, Xiaoran, et al.. (2024). A nonparametric mixed-effects mixture model for patterns of clinical measurements associated with COVID-19. The Annals of Applied Statistics. 18(3). 2080–2095. 1 indexed citations
3.
Wang, Tiantian, Shuang Wang, Chenglin Li, et al.. (2024). Baicalein alleviates cardiomyocyte death in EAM mice by inhibiting the JAK-STAT1/4 signalling pathway. Phytomedicine. 128. 155558–155558. 6 indexed citations
4.
Yang, Jiaxing, Haonan Hou, Jianing Yao, et al.. (2024). Systematic health risks assessment of chiral fungicide famoxadone: Stereoselectivities in ferroptosis-mediated cytotoxicity and metabolic behavior. Journal of Hazardous Materials. 477. 135199–135199. 3 indexed citations
5.
Zhang, Hanjie, et al.. (2024). Predicting SARS-CoV-2 infection among hemodialysis patients using deep neural network methods. Scientific Reports. 14(1). 23588–23588.
6.
Ma, Xiaoran, et al.. (2024). Higher cardiovascular disease risks in people living with HIV: A systematic review and meta-analysis. Journal of Global Health. 14. 4078–4078. 16 indexed citations
7.
Yan, Shengyu, Xiaofeng Wang, Xing Gao, et al.. (2023). Discovery of the Closest Ultra-stripped Supernova: SN 2021agco in UGC 3855. The Astrophysical Journal Letters. 959(2). L32–L32. 4 indexed citations
8.
Wei, Shijie, Xiaoran Ma, Qinqin Zhou, et al.. (2023). MAT as a promising therapeutic strategy against triple-negative breast cancer via inhibiting PI3K/AKT pathway. Scientific Reports. 13(1). 12351–12351. 8 indexed citations
9.
Wang, Shuang, Yujie Feng, Xiaoran Ma, et al.. (2023). Cotton fiber-based dressings with wireless electrical stimulation and antibacterial activity for wound repair. International Journal of Biological Macromolecules. 256(Pt 2). 128496–128496. 29 indexed citations
10.
Ma, Xiaoran, Hanjie Zhang, Caitlin Monaghan, et al.. (2023). Predicting SARS-CoV-2 infection among hemodialysis patients using multimodal data. SHILAP Revista de lepidopterología. 3. 1179342–1179342. 5 indexed citations
11.
Liang, Yiran, Donghui Liu, Yan Li, et al.. (2023). Maternal polysorbate 80 exposure causes intestinal ILCs and CD4+ T cell developmental abnormalities in mouse offspring. Environmental Pollution. 336. 122392–122392. 1 indexed citations
12.
Li, Chenglin, Shuang Wang, Xiaoran Ma, et al.. (2023). Ranitidine as an adjuvant regulates macrophage polarization and activates CTLs through the PI3K-Akt2 signaling pathway. International Immunopharmacology. 116. 109729–109729. 3 indexed citations
13.
Ye, Li, Xiaomin Wang, Xiaoran Ma, et al.. (2021). Natural Polysaccharides and Their Derivates: A Promising Natural Adjuvant for Tumor Immunotherapy. Frontiers in Pharmacology. 12. 621813–621813. 57 indexed citations
14.
Ma, Xiaoran, Huayao Li, Jing Zhuang, et al.. (2021). Identifying the Effect of Ursolic Acid Against Triple-Negative Breast Cancer: Coupling Network Pharmacology With Experiments Verification. Frontiers in Pharmacology. 12. 685773–685773. 15 indexed citations
15.
Zhang, Xiaolu, Jia Wang, Jing Zhuang, et al.. (2021). A Novel Glycolysis-Related Four-mRNA Signature for Predicting the Survival of Patients With Breast Cancer. Frontiers in Genetics. 12. 606937–606937. 13 indexed citations
16.
Ma, Xiaoran, et al.. (2021). The protective effects of allopurinol against IL-17A-induced inflammatory response in mast cells. Molecular Immunology. 141. 53–59. 3 indexed citations
17.
Liu, Cun, Xiaoran Ma, Jing Zhuang, Lijuan Liu, & Changgang Sun. (2020). Cardiotoxicity of doxorubicin-based cancer treatment: What is the protective cognition that phytochemicals provide us?. Pharmacological Research. 160. 105062–105062. 41 indexed citations
18.
Ma, Xiaoran, Jibiao Wu, Cun Liu, et al.. (2020). Deciphering of Key Pharmacological Pathways of Poria Cocos Intervention in Breast Cancer Based on Integrated Pharmacological Method. Evidence-based Complementary and Alternative Medicine. 2020(1). 4931531–4931531. 8 indexed citations
19.
Li, Jie, Cun Liu, Yi Chen, et al.. (2019). Tumor Characterization in Breast Cancer Identifies Immune-Relevant Gene Signatures Associated With Prognosis. Frontiers in Genetics. 10. 1119–1119. 54 indexed citations
20.
Li, Jie, Xiaoran Ma, Cun Liu, et al.. (2018). Exploring the Mechanism of Danshen against Myelofibrosis by Network Pharmacology and Molecular Docking. Evidence-based Complementary and Alternative Medicine. 2018(1). 8363295–8363295. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuanqiao He Breakdown of academic impact, for papers by Liangjie Yin Breakdown of academic impact, for papers by Minghua Liu Breakdown of academic impact, for papers by Yun Zhan Breakdown of academic impact, for papers by Izabela Berdowska Breakdown of academic impact, for papers by Desanka Výbohová Breakdown of academic impact, for papers by Fanying Meng Breakdown of academic impact, for papers by Xin Su Breakdown of academic impact, for papers by Mahmood Husain Qazi Breakdown of academic impact, for papers by Yao Fong
Rankless by CCL
2026